Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate
Study Information
Alliance Study ID: NCCTG-959257
NCT Study ID (ClinicalTrials.gov): NCT00006214
Disease or Cancer Type: Prostate Cancer
Alliance Study Chair: Steven R. Alberts, MD
Status: COMPLETED
Study Description
RATIONALE: Chemoprevention therapy is the use of certain drugs such as flutamide to try to prevent the development of cancer. Flutamide may be effective in the prevention of prostate cancer.
PURPOSE: Randomized clinical trial to study the effectiveness of flutamide in preventing prostate cancer in patients who have neoplasia of the prostate.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information